1. Chan JF-W, Kok K-H, Zhu Z, Chu H, To KK-W, Yuan S, et al. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerging microbes & infections. 2020;9(1):221-36. [ DOI:10.1080/22221751.2020.1719902] [ PMID] [ ] 2. Boregowda U, Aloysius MM, Perisetti A, Gajendran M, Bansal P, Goyal H. Serum activity of liver enzymes is associated with higher mortality in COVID-19: a systematic review and meta-analysis. Frontiers in medicine. 2020;7:431. [ DOI:10.3389/fmed.2020.00431] [ PMID] [ ] 3. Serafim RB, Póvoa P, Souza-Dantas V, Kalil AC, Salluh JI. Clinical course and outcomes of critically ill patients with COVID-19 infection: a systematic review. Clinical Microbiology and Infection. 2021;27(1):47-54. [ DOI:10.1016/j.cmi.2020.10.017] [ PMID] [ ] 4. Warrillow S, Austin D, Cheung W, Close E, Holley A, Horgan B, et al. ANZICS guiding principles for complex decision making during the COVID-19 pandemic. Critical Care and Resuscitation. 2020;22(2):98-102.
https://doi.org/10.51893/2022.2.O [ DOI:10.51893/2020.2.sa1] [ PMID] 5. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The lancet. 2020;395(10223):497-506. [ DOI:10.1016/S0140-6736(20)30183-5] [ PMID] 6. Wan S, Xiang Y, Fang W, Zheng Y, Li B, Hu Y, et al. Clinical features and treatment of COVID‐19 patients in northeast Chongqing. Journal of medical virology. 2020;92(7):797-806. [ DOI:10.1002/jmv.25783] [ PMID] [ ] 7. Arentz M, Yim E, Klaff L, Lokhandwala S, Riedo FX, Chong M, et al. Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State. Jama. 2020;323(16):1612-4. [ DOI:10.1001/jama.2020.4326] [ PMID] [ ] 8. Drake TM, Docherty AB, Harrison EM, Quint JK, Adamali H, Agnew S, et al. Outcome of hospitalization for COVID-19 in patients with interstitial lung disease. An international multicenter study. American journal of respiratory and critical care medicine. 2020;202(12):1656-65. [ DOI:10.1164/rccm.202007-2794OC] [ PMID] [ ] 9. Nechipurenko YD, Semyonov DA, Lavrinenko IA, Lagutkin DA, Generalov EA, Zaitceva AY, et al. The role of acidosis in the pathogenesis of severe forms of COVID-19. Biology. 2021;10(9):852. [ DOI:10.3390/biology10090852] [ PMID] [ ] 10. Wu C, Wang G, Zhang Q, Yu B, Lv J, Zhang S, et al. Association between respiratory alkalosis and the prognosis of COVID-19 patients. Frontiers in Medicine. 2021;8:564635. [ DOI:10.3389/fmed.2021.564635] [ PMID] [ ] 11. Chen T, Wu D, Chen H, Yan W, Yang D, Chen G, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. bmj. 2020;368. [ DOI:10.1136/bmj.m1091] [ PMID] [ ] 12. Kovesdy CP. Metabolic acidosis as a possible cause of CKD: what should clinicians do? American Journal of Kidney Diseases. 2014;64(4):481-3. [ DOI:10.1053/j.ajkd.2014.08.005] [ PMID] 13. Raphael KL, Zhang Y, Wei G, Greene T, Cheung AK, Beddhu S. Serum bicarbonate and mortality in adults in NHANES III. Nephrology Dialysis Transplantation. 2013;28(5):1207-13. [ DOI:10.1093/ndt/gfs609] [ PMID] [ ] 14. Mæhle K, Haug B, Flaatten H. Metabolic alkalosis is the most common acid-base disorder in ICU patients. Crit Care 18.2014; 420. [ DOI:10.1186/cc13802] [ PMID] [ ] 15. Urso C, Brucculeri S, Caimi G. Acid-base and electrolyte abnormalities in heart failure: pathophysiology and implications. Heart Fail Rev 2015;20:493-503. [ DOI:10.1007/s10741-015-9482-y] [ PMID] [ ] |
.gif){kind=logo}
